These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 9359726

  • 21. Evaluation of cefaclor and amoxycillin in the treatment of acute otitis media.
    Jacobson JA, Metcalf TJ, Parkin JL, Wenerstrom LG, Matsen JM.
    Postgrad Med J; 1979; 55 Suppl 4():39-41. PubMed ID: 44907
    [Abstract] [Full Text] [Related]

  • 22. [Causative organisms of acute otitis media and acute sinusitis in children and their susceptibility of oral beta-lactam antibiotics].
    Takenaka M, Morikawa Y, Nakagawa T, Takashima T, Haruta T, Tsuji T.
    Jpn J Antibiot; 1999 Feb; 52(2):162-71. PubMed ID: 10221181
    [Abstract] [Full Text] [Related]

  • 23. Comparative study of cefuroxime axetil suspension and amoxycillin syrup in the treatment of acute otitis media in general practice.
    Brodie DP, Griggs JV, Cunningham K.
    J Int Med Res; 1990 Feb; 18(3):235-9. PubMed ID: 2113874
    [Abstract] [Full Text] [Related]

  • 24. Ecological effects on the oro- and nasopharyngeal microflora in children after treatment of acute otitis media with cefuroxime axetil or amoxycillin-clavulanate as suspensions.
    Lund B, Edlund C, Rynnel-Dagöö B, Lundgren Y, Sterner J, Nord CE.
    Clin Microbiol Infect; 2001 May; 7(5):230-7. PubMed ID: 11422249
    [Abstract] [Full Text] [Related]

  • 25. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen.
    Leibovitz E, Greenberg D, Piglansky L, Raiz S, Porat N, Press J, Leiberman A, Dagan R.
    Pediatr Infect Dis J; 2003 Mar; 22(3):209-16. PubMed ID: 12634580
    [Abstract] [Full Text] [Related]

  • 26. Reassessment of cefaclor breakpoints for Haemophilus influenzae.
    MacKenzie FM, Milne KE, Gould IM.
    J Chemother; 2004 Aug; 16(4):329-33. PubMed ID: 15332705
    [Abstract] [Full Text] [Related]

  • 27. Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children.
    Leibovitz E, Piglansky L, Raiz S, Press J, Leiberman A, Dagan R.
    Pediatr Infect Dis J; 2000 Nov; 19(11):1040-5. PubMed ID: 11099083
    [Abstract] [Full Text] [Related]

  • 28. Comparative efficacy and safety evaluation of cefaclor vs amoxycillin + clavulanate in children with Acute Otitis Media (AOM).
    Aggarwal M, Sinha R, Murali MV, Trihan P, Singhal PK.
    Indian J Pediatr; 2005 Mar; 72(3):233-8. PubMed ID: 15812119
    [Abstract] [Full Text] [Related]

  • 29. Application of pharmacokinetic/pharmacodynamic analysis to evaluate the adequacy of antimicrobial therapy for pediatric acute otitis media in Spain before and after the introduction of the PCV7 vaccine.
    Ibar-Bariain M, Rodríguez-Gascón A, Isla A, Solinís MA, Canut-Blasco A.
    Rev Esp Quimioter; 2019 Apr; 32(2):121-129. PubMed ID: 30727714
    [Abstract] [Full Text] [Related]

  • 30. Concentration of cefuroxime in middle ear effusion of children with acute otitis media.
    Thoroddsen E, Marr C, Efthymiopoulos C, Thorarinsson H.
    Pediatr Infect Dis J; 1997 Oct; 16(10):959-62. PubMed ID: 9380472
    [Abstract] [Full Text] [Related]

  • 31. Are cephalosporins appropriate for the treatment of acute otitis media in this era of increasing antimicrobial resistance among common respiratory tract pathogens?
    Appelbaum PC.
    Clin Pediatr (Phila); 2005 Mar; 44(2):95-107. PubMed ID: 15735827
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of cefuroxime axetil, cefaclor, and amoxicillin-clavulanate potassium suspensions in acute otitis media in infants and children.
    Pichichero M, Aronovitz GH, Gooch WM, McLinn SE, Maddern B, Johnson C, Darden PM.
    South Med J; 1990 Oct; 83(10):1174-7. PubMed ID: 2218657
    [Abstract] [Full Text] [Related]

  • 33. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R.
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [Abstract] [Full Text] [Related]

  • 34. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L.
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [Abstract] [Full Text] [Related]

  • 35. Short course therapy with cefuroxime axetil for acute otitis media: results of a randomized multicenter comparison with amoxicillin/clavulanate.
    Pessey JJ, Gehanno P, Thoroddsen E, Dagan R, Leibovitz E, Machac J, Pimentel JM, Marr C, Leblanc F.
    Pediatr Infect Dis J; 1999 Oct; 18(10):854-9. PubMed ID: 10530579
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of cefaclor in acute otitis media caused by ampicillin-resistant H. influenzae.
    Schwartz RH, Rodriguez WJ, Khan WN, Brigham L, Ross S.
    Clin Pediatr (Phila); 1982 Jul; 21(7):402-4. PubMed ID: 6979453
    [Abstract] [Full Text] [Related]

  • 37. Eradication by ceftriaxone of Streptococcus pneumoniae isolates with increased resistance to penicillin in cases of acute otitis media.
    Gehanno P, Nguyen L, Barry B, Derriennic M, Pichon F, Goehrs JM, Berche P.
    Antimicrob Agents Chemother; 1999 Jan; 43(1):16-20. PubMed ID: 9869558
    [Abstract] [Full Text] [Related]

  • 38. Measuring antibiotic levels in otitis media.
    Thoroddsen E.
    Ear Nose Throat J; 1998 Jun; 77(6 Suppl):13-5. PubMed ID: 9674329
    [Abstract] [Full Text] [Related]

  • 39. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
    Perry CM, Brogden RN.
    Drugs; 1996 Jul; 52(1):125-58. PubMed ID: 8799689
    [Abstract] [Full Text] [Related]

  • 40. A multicenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrent infection.
    Arguedas A, Dagan R, Leibovitz E, Hoberman A, Pichichero M, Paris M.
    Pediatr Infect Dis J; 2006 Mar; 25(3):211-8. PubMed ID: 16511382
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.